drugset / Trial / NCT03294070
Fimasartan Plus Amlodipine on Hemodynamic Parameters and Arterial Stiffness in Patients With Hypertension
NaSingle-groupOpen-labelTreatment
Summary
24-week open clinical trial to assess tolerability and effect on pressure, hemodynamic parameters and arterial rigidity of the combined treatment based on Fimasartan 60 mg and amlodipine besylate 5 mg given once daily in patients with arterial hypertension in stages 2-3
Timeline
- Start
- 2017-09
- Primary completion
- 2018-03
- Completion
- 2018-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Amlodipine | Other / unclassified | 5 mg | — |
| Subject | Fimasartan | Small molecule | 60 mg | — |
| Background | Hydrochlorothiazide | Unknown | 12.5 mg | — |